Botulinum toxin - New mechanisms, new therapeutic directions?

European Urology

Volumn 49, Issue 4, 2006, Pages 606-608

  Chapple, Christopher ^a   Patel, Anand ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; BOTULINUM TOXIN; BOTULINUM TOXIN A; DYSPOR; SUBSTANCE P;

CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; FOLLOW UP; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION REFLEX; PRIORITY JOURNAL; SEROTYPE; SYNAPTIC TRANSMISSION; URINARY URGENCY;

BOTULINUM TOXIN TYPE A; CYSTITIS, INTERSTITIAL; HUMANS; NEUROMUSCULAR AGENTS; SYNDROME; URINARY BLADDER, OVERACTIVE;

EID: 33644864854     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.01.005     Document Type: Editorial

References (16)

1. P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, and U. Ulmsten The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178
2. C.R. Chapple, W. Artibani, L.D. Cardozo, D. Castro-Diaz, M. Craggs, and F. Haab The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects BJU Int 95 2005 335 340
3. A. Apostolides, P. Dasgupta, and C.J. Fowler Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 2006 644 650
4. V. Kumar, R.L. Cross, R. Chess-Williams, and C.R. Chapple Recent advances in basic science for overactive bladder Curr Opin Urol 15 2005 222 226
5. V. Kumar, C. Chapple, D.J. Rosario, and R. Chess-Williams Purinergic activity in sensory disorders of the bladder Eur Urol Suppl 3 2 2004 76 Abstract 295
6. C. Montecucco, and J. Molgo Botulinal neurotoxins: revival of an old killer Curr Opin Pharmacol 5 2005 274 279
7. B. Schurch, D. Hauri, B. Rodic, A. Curt, M. Meyer, and A.B. Rossier Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients J Urol 155 1996 1023 1029
8. B. Schurch, D.M. Schmid, and M. Stohrer Treatment of neurogenic incontinence with botulinum toxin A N Engl J Med 342 2000 665
9. C.P. Smith, P. Radziszewski, A. Borkowski, G.T. Somogyi, T.B. Boone, and M.B. Chancellor Botulinum toxin a has antinociceptive effects in treating interstitial cystitis Urology 64 2004 871 875 discussion 875
10. K.R. Aoki Pharmacology and immunology of botulinum toxin type A. serotypes Clinics in Dermatology 21 2003 476 480
11. A.J. Thomson, S.K. Jarvis, M. Lenart, J.A. Abbott, and T.G. Vancaillie The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles BJOG 112 2005 247 249
12. M. Khera, G.T. Somogyi, S. Kiss, T.B. Boone, and C.P. Smith Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem Int 45 2004 987 993
13. A. Apostolides, R. Popat, Y. Yiangou, D. Cockayne, A.P. Ford, and J.B. Davis Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity J Urol 174 2005 977 982 discussion 982-73
14. A. Giannantoni, E. Costantini, S.M. Di Stasi, M.C. Tascini, V. Bini, and M. Porena Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study Eur Urol 49 2006 704 709
15. T. Leippold, A. Reitz, and B. Schurch Botulinum toxin as new therapy option for voiding disorders: current state of the art. A comprehensive and up-to-date clinical review on botulinum toxin bladder and urethral injections in patients with urological dysfunctions Eur Urol 44 2003 165 174
16. G. Maria, A. Destito, and S. Lacquaniti Relief by botulinum toxin of voiding dysfunction due to prostatitis Lancet 352 1998 625